Welcome to the Upper Aerodigestive Cancer Program, which offers a multidisciplinary approach to patients with head and neck cancer, lung cancer, esophageal cancer, and mesothelioma, specializing in innovative, state-of-the-art treatment for each of these diseases.
Smoking continues to be a leading cause of cancer. Investigators in the newly developed Upper Aerodigestive Cancer program focus their attention on cancers most directly linked to tobacco use, including lung, head and neck, and esophageal cancers. Among their discoveries is the identification of a series of molecular events that contribute to cancer development. These events include both genetic mutations and other molecular alterations affecting gene expression. Taken together, these molecular markers are being used to detect precancerous changes, to diagnose cancers, and to guide surgeons in removing tumors. In oral cancers, where every cut can potentially impact a patient’s speech or appearance, these markers may help surgeons precisely pinpoint cancer cells and spare normal tissue. These molecular events also represent potential targets for improving drug therapy for these diseases. A number of new biologic therapies directed against molecular alterations specific to the cancer are being evaluated and show promise for patients with cancers of the lung, head and neck and esophagus.
Appointments
Newly diagnosed patients who would like a surgery consultation should call:
410-614-3891
Medical Oncology: 410-955-8964
Meet Our Team
Lung Cancer Prevention Trials
Lung Cancer Resource links
